Home
Company
Therapeutic Focus
Pipeline
UNI-494
Renazorb
Investors
Resources
Contact
Archives:
Resources
Renazorb Sevelamer In-Vivo Phosphate Reduction Study
May 15, 2023
Renazorb Phosphate Binders Daily Medication Volume Poster
May 15, 2023
UNI-494 DOG 28-Day Oral Toxicity Study
May 15, 2023
UNI-494 InVitro Drug Interaction- Poster
May 15, 2023
Renazorb- Phase 1 Clinical Study Poster
May 12, 2023
UNI-494 Preclinical PK Poster
May 12, 2023
